October 05, 2026 — RNews

#glycemic control — Monday, October 05, 2026 (1 items)

hot top new

← prev day next day →

12

Oral small-molecule GLP-1RA safiglipron versus dapagliflozin in type 2 diabetes: a randomized, double-blind, active-comparator-controlled phase 3 trial. (nature.com)

Guo L … Ye Z Nature Medicine 2026-10-05

#diabetes #clinical trial #pharmacotherapy #glycemic control